CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus

Area of Science:

• Epigenetics
• Cancer Biology
• Molecular Genetics

Background:

• The INK4B-ARF-INK4A (INK/ARF) locus contains crucial tumor suppressor genes frequently silenced by DNA methylation in various cancers.
• A non-coding RNA, ANRIL, is transcribed upstream of the ARF gene, influencing the locus's regulation.
• The divergent promoter region is normally bound by CTCF and associated with specific histone modifications.

Purpose of the Study:

• To investigate the role of CTCF in regulating the INK/ARF locus.
• To understand how DNA methylation affects CTCF binding and gene expression at this locus.
• To determine if CTCF is necessary for the reactivation of INK/ARF genes by demethylating agents.

Main Methods:

• Chromatin immunoprecipitation (ChIP) to assess CTCF binding and histone modifications.
• RNA interference (RNAi) to knock down CTCF expression.
• Treatment with 5-Aza-2'-deoxycytidine (5-Aza-dC) to induce demethylation and gene expression.
• Quantitative PCR to measure gene expression levels.

Main Results:

• DNA methylation of a CpG island in the promoter region prevents CTCF binding and associated histone modifications.
• 5-Aza-dC treatment restores CTCF binding and gene expression, indicating reversibility.
• CTCF knockdown significantly impairs the induction of ANRIL, ARF, INK4A, and INK4B by 5-Aza-dC.
• CTCF is crucial for the transcriptional activation of the entire INK/ARF locus.

Conclusions:

• CTCF acts as a key factor for the transcription of the INK/ARF locus.
• Disruption of CTCF binding by DNA methylation contributes to the stable silencing of these tumor suppressor genes in cancer.
• Targeting CTCF or reversing its methylation could be potential therapeutic strategies for cancers with silenced INK/ARF genes.